BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15995571)

  • 21. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder.
    Ehrenreich M; Tarlow MM; Godlewska-Janusz E; Schwartz RA
    Cutis; 2007 May; 79(5):355-62. PubMed ID: 17569396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Onset of disseminated Bloch-Sulzberger incontinentia pigmenti].
    Schaller J; Kock M; Goos M
    Hautarzt; 1992 Jun; 43(6):383-5. PubMed ID: 1628974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.
    Culić V; Gabrić D; Puizina-Ivić N; Rozman K; Peterlin B; Pavelić J
    Coll Antropol; 2008 Dec; 32(4):1259-62. PubMed ID: 19149237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bloch-Sulzberger incontinentia pigmenti with associated neurologic and ophthalmologic complications].
    Petri H; Pierchalla P; Tronnier H
    Z Hautkr; 1988 Jul; 63(7):568-72. PubMed ID: 3188603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incontinentia pigmenti in a male infant with Klinefelter syndrome: a case report and review of the literature.
    Buinauskaite E; Buinauskiene J; Kucinskiene V; Strazdiene D; Valiukeviciene S
    Pediatr Dermatol; 2010; 27(5):492-5. PubMed ID: 20807362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incontinentia pigmenti or Bloch-Sulzberger syndrome: a rare X-linked genodermatosis.
    Marques GF; Tonello CS; Sousa JM
    An Bras Dermatol; 2014; 89(3):486-9. PubMed ID: 24937825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De Novo incontinentia pigmenti in female twins.
    Su PH; Chen JY; Yu JS; Su CM; Huang TC; Chen SJ
    Acta Paediatr Taiwan; 2004; 45(3):178-80. PubMed ID: 15493740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incontinentia pigmenti in boys: a series and review of the literature.
    Ardelean D; Pope E
    Pediatr Dermatol; 2006; 23(6):523-7. PubMed ID: 17155991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incontinentia pigmenti: overcoming cosmetic challenges.
    Rouse JS
    Compend Contin Educ Dent; 1999 Nov; 20(11):1034-6, 1038, 1040-1. PubMed ID: 10650389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incontinentia pigmenti: seven cases with dental manifestations.
    Macey-Dare LV; Goodman JR
    Int J Paediatr Dent; 1999 Dec; 9(4):293-7. PubMed ID: 10815588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incontinentia pigmenti: three new cases that demonstrate it is not only a matter of women].
    Feito-Rodríguez M; García-Macarrón J; Bravo-Burguillos ER; Vera-Casaño A; de Lucas-Laguna R
    Actas Dermosifiliogr; 2007 Mar; 98(2):112-5. PubMed ID: 17397599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incontinentia pigmenti with a foreshortened hand: evidence for the significance of NFkappaB in human morphogenesis.
    Kmetz EC; Shashidhar Pai G; Burges GE
    Pediatr Dermatol; 2009; 26(1):83-6. PubMed ID: 19250414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
    Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
    Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal seizures in two sisters with incontinentia pigmenti.
    Pörksen G; Pfeiffer C; Hahn G; Poppe M; Friebel D; Kreuz F; Gahr M
    Neuropediatrics; 2004 Apr; 35(2):139-42. PubMed ID: 15127315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients.
    Zou CC; Zhao ZY
    Int J Dermatol; 2007 Oct; 46(10):1017-22. PubMed ID: 17910706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress in the genetics of incontinentia pigmenti (Bloch-Sulzberger syndrome).
    Shastry BS
    J Hum Genet; 2000; 45(6):323-6. PubMed ID: 11185738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incontinentia pigmenti: variable disease expression within an affected family.
    Basarab T; Dunnill MG; Munn SE; Russell-Jones R
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):173-6. PubMed ID: 9784048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age].
    Portaleone D; Taroni F; Micheli S; Moioli M; Pedrazzini A; Cognizzoli P; Carnelli V
    Minerva Pediatr; 2007 Jun; 59(3):255-65. PubMed ID: 17519871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General and dental characteristics of Bloch-Sulzberger syndrome. Review of literature and presentation of a case report.
    Domínguez-Reyes A; Aznar-Martin T; Cabrera-Suarea E
    Med Oral; 2002; 7(4):293-7. PubMed ID: 12134130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incontinentia pigmenti (Bloch-Sulzberger syndrome): seven case reports from one family.
    Spallone A
    Br J Ophthalmol; 1987 Aug; 71(8):629-34. PubMed ID: 3115288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.